Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI listens for signs of depression, autism, and more in your speech

NCT ID NCT06792175

Diagnosis Sponsor: Psyrin Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether artificial intelligence can analyze a person's speech to help diagnose mental health conditions like depression, anxiety, autism, and schizophrenia. Researchers will record 500 people speaking and compare the AI's predictions to standard clinical diagnoses. The goal is to create a tool that supports doctors in making faster and more accurate assessments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Solicue Machine Learning Models (speech analysis AI)
What this could lead to
If successful, this could give doctors a fast, objective tool to help diagnose mental health conditions using just a voice recording.
What could go wrong
This is an early-stage study. The AI may not be accurate enough for real-world use, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The MIND AIM study aims to recruit a diverse and representative sample of individuals seeking mental health assessments in various clinical settings. This broad inclusion criteria ensures high ecological validity, capturing the wide range of presentations and comorbidities commonly encountered in real-world mental health practice.

Ages

13 to 60 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Participants aged between 16 and 60 years. 2. Individuals currently undergoing or referred for clinical assessment of mental or behavioral health conditions (including but not limited to ADHD, ASD, BPAD, GAD, MDD, OCD, PTSD, SSD) 3. Fluent in English 4. Capable of providing informed consent, or in the case of minors, having a parent or legal guardian who can provide consent on their behalf. 5. Access to a device (smartphone, tablet, or computer) with a microphone and stable internet connectivity, necessary for completing the speech tasks. Exclusion Criteria 1. Individuals experiencing acute mental health crises or severe symptoms that would preclude meaningful participation in the study, including acute intoxication. 2. Severe cognitive impairment or intellectual disability that would prevent understanding of the study procedures or completion of the speech tasks. 3. Lack of fluency in English. 4. Technical limitations: Inability to access a suitable device or internet connection for completing the speech tasks

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety, generalized are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder autism spectrum disorder bipolar disorder generalized anxiety disorder major depressive disorder obsessive-compulsive disorder post-traumatic stress disorder Psychological Well-Being psychotic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety, generalized Attention-deficit/hyperactivity disorder (ADHD) Autism spectrum disorder Bipolar disorder (BD) Depression - major depressive disorder Obsessive compulsive disorder (OCD) Post-traumatic stress disorder Schizophrenia spectrum & other psychotic disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Allwell Behavioral Health Services

    Zanesville, Ohio, 43701, United States

  • The Brookline Center

    Brookline, Massachusetts, 02445, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.